Dow Up0.11% Nasdaq Up0.50%

Ocera Therapeutics, Inc. (OCRX)

-NasdaqGM
5.93 Up 0.09(1.54%) Aug 29, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 85   -   10,167  
Cost of Revenue -   -   -  
Gross Profit 85   -   10,167  
Operating Expenses
Research Development3,549  1,642  24,884  
Selling General and Administrative8,500  1,739  6,028  
Non Recurring3,070   -   -  
Others295   -   -  
Total Operating Expenses15,414   -   -  
Operating Income or Loss (15,329) (3,381) (20,745)
Income from Continuing Operations
Total Other Income/Expenses Net33  (43)126  
Earnings Before Interest And Taxes(15,296)(3,424)(20,619)
Interest Expense193  184  1,589  
Income Before Tax(15,489)(3,608)(22,208)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(15,489)(3,608)(22,208)
Non-recurring Events
Discontinued Operations(2,025) -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (17,514) (3,608) (22,208)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (17,514) (3,608) (22,208)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.